Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Mol Cancer Ther. 2019 Jun 4;18(8):1451–1459. doi: 10.1158/1535-7163.MCT-18-1125

Table 2.

Outcome of older patients (aged ≥ 60 years) with cytogenetically normal acute myeloid leukemia by low and high long non-coding RNA (lncRNA) score status

End point Low lncRNA score (n=38) High lncRNA score (n=38) P

Complete remission 0.009
n, (%) 33 (87) 22 (58)

Disease-free survival 0.05
 Median, years 0.5 0.5
 Disease-free at 3 years, % (95% CI) 21 (9–36) 0
 Disease-free at 5 years,% (95% CI) 21 (9–36) 0

Overall survival 0.02
 Median, years 1.2 0.9
 Alive at 3 years, % (95% CI) 29 (16–44) 10 (3–22)
 Alive at 5 years, % (95% CI) 26 (13–40) 5 (0–18)

Event-free survival 0.002
 Median, years 0.6 0.3
 Event-free at 3 years, % (95% CI) 18 (8–32) 0
 Event-free at 5 years,% (95% CI) 18 (8–32) 0

Abbreviations: n, number; CI, confidence interval.